(Total Views: 4469)
Posted On: 03/09/2017 9:32:31 AM
Post# of 223
BioPharmX to Present at 29th Annual ROTH Conference
MENLO PARK, Calif., March 9, 2017 – BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today announced that its updated corporate presentation will be webcast from the 29th Annual ROTH Conference in Dana Point, Calif.
BioPharmX co-founder and President Anja Krammer will provide an updated overview of the company at the conference on Monday, March 13, at 10 a.m. PST in Pink – Salon 5 conference room of the Ritz Carlton Hotel.
The live webcast will be available at http://wsw.com/webcast/roth31/bpmx and a replay will be accessible for 90 days following the presentation.
The annual ROTH Conference, hosted by ROTH Capital Partners March 12 to 15, is one of the largest gatherings of institutional investors, private equity investors, VCs, company executives and service providers in the small- and mid-cap space.
MENLO PARK, Calif., March 9, 2017 – BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today announced that its updated corporate presentation will be webcast from the 29th Annual ROTH Conference in Dana Point, Calif.
BioPharmX co-founder and President Anja Krammer will provide an updated overview of the company at the conference on Monday, March 13, at 10 a.m. PST in Pink – Salon 5 conference room of the Ritz Carlton Hotel.
The live webcast will be available at http://wsw.com/webcast/roth31/bpmx and a replay will be accessible for 90 days following the presentation.
The annual ROTH Conference, hosted by ROTH Capital Partners March 12 to 15, is one of the largest gatherings of institutional investors, private equity investors, VCs, company executives and service providers in the small- and mid-cap space.
(0)
(0)
